Your session is about to expire
← Back to Search
Procedure
Treatment for Movement Disorders (LAANTERN Trial)
N/A
Waitlist Available
Led By Eric Leuthardt, MD
Research Sponsored by Monteris Medical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 12 months
Awards & highlights
No Placebo-Only Group
Summary
The NeuroBlate® System (NBS) is a minimally invasive robotic laser thermotherapy tool that is being manufactured by Monteris Medical. Since it received FDA clearance in May 2009, the NBS has been used in over 2600 procedures conducted at over 70 leading institutions across United States. This is a prospective, multi-center registry that will include data collection up to 5 years to evaluate safety, QoL, and procedural outcomes including local control failure rate, progression free survival, overall survival, and seizure freedom in up to 1,000 patients and up to 50 sites.
Eligible Conditions
- Epilepsy
- Movement Disorders
- Brain Tumor
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 12 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in Quality of Life
Number of patients demonstrating local control, overall survival, and seizure freedom (ENGEL and ILAE classifications)
Reason for NeuroBlate
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Find a Location
Who is running the clinical trial?
Monteris MedicalLead Sponsor
9 Previous Clinical Trials
563 Total Patients Enrolled
Eric Leuthardt, MDPrincipal InvestigatorWashington University School of Medicine
1 Previous Clinical Trials
56 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger